Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Ointments: SOP for Stability Testing in Varied Humidity Conditions – V 2.0

Posted on By

SOP for Stability Testing in Varied Humidity Conditions – V 2.0

Procedure for Stability Testing in Varied Humidity Conditions

Department Quality Control (QC)/Quality Assurance (QA)/Research & Development (R&D)
SOP No. SOP/Ointment/103
Supersedes V 1.0
Page No. Page X of Y
Issue Date [Insert Issue Date]
Effective Date [Insert Effective Date]
Review Date [Insert Review Date]

1. Purpose

The purpose of this Standard Operating Procedure (SOP) is to define the procedure for conducting stability testing of ointments under varied humidity conditions to assess their physical, chemical, and microbiological stability when exposed to different environmental humidity levels.

2. Scope

This SOP applies to all personnel in the Quality Control (QC), Quality Assurance (QA), and Research & Development (R&D) departments responsible for executing, monitoring, and documenting humidity-controlled stability studies.

3. Responsibilities

  • QC Analyst: Conducts stability testing under different humidity conditions.
  • QC Supervisor: Ensures compliance with stability study protocols.
  • QA Officer: Reviews stability test data for regulatory compliance.
  • R&D Scientist: Interprets data trends and suggests formulation improvements if required.
  • QA Manager: Approves stability study protocols and ensures regulatory adherence.
See also  Ointments: SOP for Documenting Process Validation Studies - V 2.0

4. Accountability

The QA and QC Managers are accountable for ensuring compliance with ICH Q1A(R2) guidelines for stability testing under different humidity conditions.

5. Procedure

5.1 Preparation for Stability Testing

  • Ensure the stability study protocol is approved before initiation.
  • Select representative ointment batches for testing.
  • Label stability samples with batch number, manufacturing date, and storage conditions.
  • Store samples
under specified humidity conditions in stability chambers.

5.2 Storage Conditions for Humidity Testing

  • 25°C ± 2°C / 40% RH ± 5% RH (Low Humidity Conditions)
  • 25°C ± 2°C / 60% RH ± 5% RH (Standard Conditions)
  • 30°C ± 2°C / 65% RH ± 5% RH (Intermediate Conditions)
  • 40°C ± 2°C / 75% RH ± 5% RH (High Humidity Conditions)

5.3 Stability Testing Parameters

  • Physical Properties: Observe changes in texture, phase separation, or liquefaction.
  • Chemical Stability: Assess active ingredient content and degradation products.
  • Microbiological Testing: Perform microbial limit tests to detect contamination.
  • pH Measurement: Determine the impact of humidity on pH values.
  • Viscosity Analysis: Evaluate changes in consistency and spreadability.

5.4 Sampling Intervals

  • Collect stability samples at predefined intervals: 0, 3, 6, 9, 12, 18, and 24 months.
  • Perform tests as per the stability study protocol.
  • Document all test results in the Stability Testing Log.

5.5 Handling Out-of-Specification (OOS) Results

  • Identify any deviations from the acceptance criteria.
  • Initiate an Out-of-Specification (OOS) investigation if required.
  • Implement corrective and preventive actions (CAPA) as needed.

5.6 Documentation and Data Analysis

  • Record all test results in the Stability Study Report.
  • Ensure data integrity and traceability.
  • QA must approve stability data before finalizing the report.

6. Abbreviations

  • GMP – Good Manufacturing Practices
  • QA – Quality Assurance
  • QC – Quality Control
  • ICH – International Council for Harmonisation
  • RH – Relative Humidity
  • OOS – Out-of-Specification

7. Documents

  • Stability Testing Log (Annexure-1)
  • Humidity-Based Stability Study Report (Annexure-2)

8. References

  • ICH Q1A(R2) Stability Testing of New Drug Substances and Products
  • WHO GMP Guidelines for Pharmaceutical Stability Studies

9. SOP Version

Version 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Stability Testing Log

Date Batch Number Storage Condition Testing Interval Parameter Tested Result Reviewed By
01/02/2025 OINT-301 25°C/40% RH 6 Months Viscosity Compliant QA Officer
01/08/2025 OINT-301 40°C/75% RH 12 Months pH Stable QA Officer

Annexure-2: Humidity-Based Stability Study Report

Batch Number Study Start Date Study End Date Test Parameters Results Final Conclusion
OINT-301 01/02/2025 01/02/2027 pH, Viscosity, Microbial Limits Compliant Meets Stability Criteria
OINT-302 01/03/2025 01/03/2027 Appearance, Assay, Microbial Limits Compliant Meets Stability Criteria

12. Revision History:

Revision Date Revision No. Details of Revision Reason for Revision Approved By
01/01/2024 1.0 Initial Version New SOP QA Head
01/02/2025 2.0 Updated SOP Format Standardization of Document QA Head
See also  Ointments: SOP for Requalification of Key Equipment - V 2.0
Ointments V 2.0 Tags:Ointment application SOP, Ointment batch record SOP, Ointment compounding SOP, Ointment dispensing SOP, Ointment filling SOP, Ointment formulation SOP, Ointment manufacturing SOP, Ointment microbiological testing SOP, Ointment pH testing SOP, Ointment production SOP, Ointment quality control SOP, Ointment stability study SOP, Pharmaceutical ointment SOP, SOP for ointment homogenization, SOP for ointment labeling, SOP for ointment mixing, SOP for ointment packaging, SOP for ointment preparation, SOP for ointment raw material testing, SOP for ointment shelf-life determination, SOP for ointment stability testing, SOP for ointment sterilization, SOP for ointment storage, SOP for ointment testing, SOP for ointment viscosity testing

Post navigation

Previous Post: Tablets: SOP for Dissolution Method Development for Sustained Release Tablets – V 2.0
Next Post: SOP for Handling Complaints Related to Quarantined Raw Materials – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version